doi: 10.1038/nmeth1019 18 BenjaminiYHochbergY
While the GIPR antagonist alone provides little weight loss in DIO mice, its combination with the GLP-1R agonist liraglutide nearly doubles the weight loss seen with liraglutide alone
Eur J Heart Fail 22:14951503 Seferovi PM, Fragasso G, Petrie M, Mullens W, Ferrari R, Thum T, Bauersachs J, Anker SD, Ray R, avuolu Y, Polovina M, Metra M, Ambrosio G, Prasad K, Seferovi J, Jhund PS, Dattilo G, elutkiene J, Piepoli M, Moura B, Chioncel O, Ben Gal T, Heymans S, Jaarsma T, Hill L, Lopatin Y, Lyon AR, Ponikowski P, Lainak M, Jankowska E, Mueller C, Cosentino F, Lund LH, Filippatos GS, Ruschitzka F, Coats AJS, Rosano GMC (2020) Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failure
This release was published on openPR
He's a Type2 diabetic
Another benefit is the steady momentum created by glp 1 weight loss programs